Latest NewsOct 30, 2025HiFiBiO Therapeutics Announces the Appointment of Leading I&I Experts to its Scientific Advisory BoardAll Filter By: Year20252024202320222021202020192018201720162015May 11, 2021HiFiBiO Therapeutics Announces Publication in Nature Communications on its SARS-CoV-2 Neutralizing Monoclonal AntibodyApr 12, 2021Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibodyApr 12, 2021HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancersApr 12, 2021Mechanism of Action and Biomarker Strategy for HFB200301, an Anti-TNFR2 Agonist Antibody for the Treatment of CancerApr 12, 2021Discovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomas< 1 … 7 8 9 10 11 … 18 >
